兽医 CRO 市场概览、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPRE00008083
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Veterinary CRO Market Size, Share, and CAGR by 2031

Buy Now

兽医 CRO 市场规模预计将从 2023 年的 9.964 亿美元增至 2031 年的 21.4574 亿美元。预计 2023-2031 年市场复合年增长率为 10.1%。对临床前研究服务的需求不断增长以及技术和数字解决方案的采用可能仍然是市场的主要趋势。

兽医CRO市场分析

由于宠物数量不断增加以及人们对动物健康意识的不断提高,对动物保健的需求不断增长,推动了兽医CRO市场的发展。为了满足对动物不断增长的需求,增加了研发活动,推动了兽医 CRO 市场的增长。此外,市场上不断涌现的战略合作,例如合并、收购和合作伙伴关系,旨在开发用于诊断和治疗动物各种健康状况的先进产品。此外,由于对肉制品的需求增加,对农场动物的药物需求增加预计也将推动市场增长。此外,动物生物仿制药和疫苗的不断发展预计将在未来几年为兽医 CRO 市场创造充足的机会。

兽医CRO市场概况

由于过去几年动物特异性研发活动和临床试验的激增,预计兽医 CRO 市场将呈现显着增长。这主要归因于用于治疗动物各个治疗领域的新药物分子和医疗器械的数量不断增加,以及在兽药和器械批准之前满足严格的监管要求的要求。此外,北美地区在 2023 年在所有地区中占据最大份额,由于该国伴侣动物拥有量的增加以及动物医疗保健支出的激增,预计到 2031 年将主导市场。 2023年,亚太地区成为全球兽医CRO市场增长最快的地区,预计在预测期内将以更快的速度增长。该地区兽药CRO市场的增长主要归因于成熟的医药市场、制药和生物制药公司研发支出的增加、有利的监管政策、生产和研发成本较低以及该地区制药和生物技术公司数量的增加。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

兽医 CRO 市场:

兽医CRO市场
  • Veterinary CRO Market
    年均复合增长率(2023 - 2031)
    10.1%
  • 2023年市场规模
    9.964亿美元
  • 2031 年市场规模
    214574 万美元

市场动态

增长动力
  • 提高动物健康意识有助于兽药开发
未来的趋势
  • 市场参与者之间战略合作的激增推动研究
机会
  • 开发动物新型疫苗创造充足机会

关键人物;主力;重要一员

  • 克林维特
  • Löhlein 和 Wolf 兽医研究中心
  • Oncovet 临床研究
  • 昂达克斯科学公司
  • 特里韦里塔斯
  • 兽医研究管理
  • 兽医制药公司
  • 维茨平有限公司

区域概况

Veterinary CRO Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Veterinary CRO Market服务类型
  • 临床试验
  • 毒理学
  • 市场授权和监管支持
Veterinary CRO Market应用
  • 宠物
  • 家畜
  • 荒野
Veterinary CRO Market指示
  • 肿瘤学
  • 传染性疾病
  • 神经病学
Veterinary CRO Market最终用户
  • 制药公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

兽医 CRO 市场驱动因素和机遇

市场参与者战略合作激增,利好市场

市场上的战略举措激增,其中包括对兽医 CRO 领域运营的各种市场参与者进行并购。这将有助于市场参与者在指数增长中保持竞争力和灵活性,并且还允许制造商访问彼此的技术、平台,这将进一步帮助他们显着增长。市场上最近采取的一些战略举措如上所述。 2023年5月,Argenta 收购了 Midwest Veterinary Services, Inc. 的 CRO 服务,因为这将使两家组织能够为客户提供更广泛的临床研究、产品开发和制造服务。此外,GD Group 于 2022 年 12 月收购了 Agrobiogen GmbH、Xenogenetik Ges.mbH、Nexttec GmbH 和 Nexttec Inc。Agrobiogen 和 Xenogenetik 专注于分子遗传学研究和兽医诊断,Nexttec 生产创新的 DNA 提取试剂盒。因此,市场参与者之间战略合作的增加将促进动物先进诊断和治疗的发展,并有助于兽医 CRO 市场的增长。

动物生物仿制药和疫苗的开发

生物仿制药和兽用疫苗等生物治疗药物是制药行业增长最快的领域。生物疗法的功效和安全性与治疗动物中各种无法治疗的疾病(如无吸虫病、血吸虫病、猪瘟、沙门氏菌病)的能力相关,因此需要更多的临床试验。技术进步以及对癌症、类风湿性关节炎等疾病认识的显着提高,对生物仿制药和兽用疫苗的开发产生了需求。

制药和生物制药公司主要投资于研发活动,以开发创新和先进的生物分子。公司正在利用其在生物制品制造方面的专业知识,通过满足未满足的条件来创造更多收入。近年来,疫苗的投放和推广有所增加。

FDA 批准 NDA 或疫苗批准之前所需的步骤通常包括临床前研究,然后是多个阶段的临床试验。为了节省生物制剂和生物仿制药初始阶段整个开发过程中这些测试服务所需的内部成本和时间,公司更愿意将这些服务外包给兽医CRO。预计这将成为未来几年全球兽医 CRO 发展的潜在机会。

兽医CRO市场报告细分分析

有助于得出兽医 CRO 市场分析的关键部分是服务类型、应用、适应症和最终用户。

  • 根据服务类型,兽医 CRO 市场分为临床试验、毒理学、市场授权和监管支持等。 2023 年,临床试验领域占据最大的市场份额。
  • 按用途,市场分为宠物、牲畜、野生。 2023 年,宠物细分市场占据最大市场份额。
  • 就适应症而言,市场分为肿瘤学、传染病学、神经学等。 2023 年,肿瘤学领域占据最大的市场份额。
  • 按最终用户划分,市场分为制药公司和其他公司。 2023 年,制药公司细分市场占据较大份额。

按地域划分的兽医 CRO 市场份额分析

兽医CRO市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲和中美洲。

北美市场占据主导地位。由于动物疾病患病率显着增加、动物保健和福利计划等政府举措不断增加、伴侣动物的采用率不断上升、畜牧业和乳制品行业不断发展,美国兽医 CRO 市场的增长预计将增长。在加拿大,由于宠物行业的崛起和改善兽医医疗基础设施的投资增加,预计市场将增长。在墨西哥,由于为临床研究提供监管支持、市场授权和毒理学服务等支持服务的公司数量不断增加,该市场预计将增长。预计亚太地区未来几年将以最高的复合年增长率增长。

兽医 CRO 市场报告范围

报告属性细节
2023年市场规模9.964亿美元
2031 年市场规模214574万美元
全球复合年增长率(2023 - 2031)10.1%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按服务类型
  • 临床试验
  • 毒理学
  • 市场授权和监管支持
按申请
  • 宠物
  • 家畜
  • 荒野
按指示
  • 肿瘤学
  • 传染性疾病
  • 神经病学
按最终用户
  • 制药公司
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 克林维特
  • Löhlein 和 Wolf 兽医研究中心
  • Oncovet 临床研究
  • 昂达克斯科学公司
  • 特里韦里塔斯
  • 兽医研究管理
  • 兽医制药公司
  • 维茨平有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

兽医 CRO 市场新闻和最新动态

兽医 CRO 市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了兽医 CRO 市场的一些发展:

  • Transpharmation Canada Ltd. 和兽医健康研究中心 LLC (VHRC) 合作,通过提供高质量的转化药物发现服务来加速药物发现计划,此次合作将使 Transpharmation 进行的临床前工作无缝过渡到概念验证或预验证。 -使用具有传统研究群体中无法获得的真实条件的动物进行 IND/INAD 临床试验。 (来源:兽医健康研究中心有限责任公司,新闻稿,2023 年)
  • Argenta 收购了西班牙临床开发专家 Ondax Scientific,以加强临床研究能力和服务。该交易将 Argenta 的 CRO 业务版图进一步扩大到南欧和西欧,使其能够接触新客户并加强其临床、质量保证和数据管理能力。 (来源:Argenta,公司网站,2022 年)

Argenta 收购了 Klifovet,合并后的业务将成为全球性的全价值战略合作伙伴,刺激创新并为大型和小型动物健康和营养公司提供支持。 Klifovet 将特别补充 Argenta 位于美国的临床和监管服务团队,提供无与伦比的专业知识,并获得动物健康领域最大的跨大西洋 CRO 能力。 (来源:Argenta,时事通讯,2021 年)

兽医 CRO 市场报告范围和可交付成果

《兽医CRO市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 兽医 CRO 市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 兽医 CRO 市场趋势以及市场动态,例如驱动因素、限制因素和关键机会
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 兽医 CRO 市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖兽医 CRO 市场的市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the veterinary CRO market in 2023?

North America region is dominated the veterinary CRO market in 2023.

What are the driving factors impacting the veterinary CRO market?

Factors impacting the veterinary CRO market includes increasing demand for animal healthcare and surge in strategic collaborations among market players

What are the future trends of the veterinary CRO market?

Increasing demand for preclinical research services and adoption of technology and digital solutions are the future trends of the veterinary CRO market

Which are the leading players operating in the veterinary CRO market?

The leading players operating in the veterinary CRO market includes Clinvet, Löhlein & Wolf Vet Research, Oncovet Clinical Research, Ondax Scientific, Triveritas, Veterinary Research Management, VetPharm, Inc., and Vetspin Srl among others

What would be the estimated value of the veterinary CRO market by 2031?

The the estimated value of the veterinary CRO market by 2031 is US$ 2.14 Bn

What is the expected CAGR of the veterinary CRO market?

The expected CAGR of the veterinary CRO market from 2023-2031 is 10.1%

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..